After a few weeks of intense training in the Career Forge program, she says adults of all ages find open doors to new careers with more upward mobility, income, and flexibility.
“I never really pictured myself doing this this,” Augustin said.
“The ideas that we try to cover are all the different techniques that you need to start at an entry level research position.” Dr. Chi said. “This curriculum is written so that anyone who's interested in sciences can interact.”So what happens after you complete the Career Forge program? Graduates like Marisa Lemus get jobs in biotech. She is a senior at Northeastern, is getting a Masters Degree next and is working at Satellite Bio.
“I had a goal and it wasn’t a straight pathway. It was ups and downs," she added."I had people out in the industry that have helped me to move forward and that is why I am here today.” “I'm always the first one to either be an a panel of scientists, like, immigrant women, single mothers, and usually always the only Latina present in most of the scientific exchanges that we have," she said."I think that makes him proud. He keeps saying, 'you're always the first.'”
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
‘Gratitude is my Religion:' Thankful Vt. Cancer Survivor Launching Aviation NonprofitA woman from Vermont’s Franklin County is pledging to live every day as if it is Thanksgiving, expressing deep gratitude to be alive and channeling that energy into uplifting youth through a new nonprofit. “I used to say, ‘Gratitude is my religion,’” Beth White said Thanksgiving morning as the hobbyist pilot prepared for a flight from the Franklin County State…
Read more »
An mRNA-based rabies vaccine induces strong protective immune responses in mice and dogs - Virology JournalRabies is a lethal zoonotic disease that is mainly caused by the rabies virus (RABV). Although effective vaccines have long existed, current vaccines take both time and cost to produce. Messenger RNA (mRNA) technology is an emergent vaccine platform that supports rapid vaccine development on a large scale. Here, an optimized mRNA vaccine construct (LVRNA001) expressing rabies virus glycoprotein (RABV-G) was developed in vitro and then evaluated in vivo for its immunogenicity and protective capacity in mice and dogs. LVRNA001 induced neutralizing antibody production and a strong Th1 cellular immune response in mice. In both mice and dogs, LVRNA001 provided protection against challenge with 50-fold lethal dose 50 (LD50) of RABV. With regards to protective efficiency, an extended dosing interval (14 days) induced greater antibody production than 3- or 7-day intervals in mice. Finally, post-exposure immunization against RABV was performed to evaluate the survival rates of dogs receiving two 25 μg doses of LVRNA001 vs. five doses of inactivated vaccine over the course of three months. Survival rate in the LVRNA001 group was 100%, whereas survival rate in the inactivated vaccine control group was only 33.33%. In conclusion, these results demonstrated that LVRNA001 induced strong protective immune responses in mice and dogs, which provides a new and promising prophylactic strategy for rabies.
Read more »
‘The low-level sexism in our society makes violence against women seem inevitable’ Laura Bates on the fight to eliminate gender-based violence'It's about putting the focus where it belongs, onto actionable solutions that don't involve blaming victims.'
Read more »
Sausage-skin maker Devro agrees to £540m takeoverNorth Lanarkshire-based Devro says the deal with German-owned Saria is 'attractive'.
Read more »
Ffern’s first London store is a haven of natural fragrance and sustainable designFfern, the Somerset-based natural fragrance brand, has opened its first physical store, in London’s Soho
Read more »